DENTSPLY SIRONA EV/EBIT XRAY

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2010.

Today, Oct 23, 2026: n/m; an operating loss
Last meaningful: 279×; Feb 2026
10-year median: 34.5×
10-year range: 11.5× to 294×
Peer median: 26.2×

DENTSPLY SIRONA has no meaningful EV/EBIT today: it made an operating loss of $310M over the last twelve months.

It was last meaningful in Feb 2026, at 279×.

On the days it had one over the last ten years, its median was 34.5×, from 11.5× in Nov 2022 to 294× in Feb 2026.

EV/EBIT over time

median 34.5×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	279×	263×	294×
2025	267×	32.9×	267×
2024	33.9×	30.4×	53.6×
2023	52.4×	43.8×	59.7×
2022	13.0×	11.5×	21.8×
2021	20.9×	18.9×	91.8×
2020	82.9×	21.0×	84.9×
2019	23.9×	23.7×	53.6×
2018	42.1×	27.3×	45.4×
2017	44.1×	30.6×	45.2×
2016	31.5×	18.7×	36.7×
2015	22.6×	18.3×	23.3×
2014	20.0×	17.6×	20.7×
2013	19.9×	17.7×	20.0×
2012	18.4×	17.7×	20.6×
2011	17.7×	11.3×	18.1×
2010	13.0×	11.1×	14.1×

Against its peers

Companies in Medical - Instruments & Supplies nearest DENTSPLY SIRONA's size, closest first, today.

Company	EV/EBIT
XRAYDENTSPLY SIRONA	n/m
LMATLemaitre Vascular	22.6×
INSPInspire Medical Systems	32.6×
UFPTUFP Technologies	24.9×
EYENational Vision	19.2×
CDRECadre	23.2×
BVSBioventus	26.2×
ATRCAtriCure	208×
STAAStaar Surgical	57.7×
WRBYWarby Parker	n/m
IRMDIradimed	37.7×
Peer median	26.2×

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on DENTSPLY SIRONA

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.